Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annualized) and $0.06042 for...
-
WEST PALM BEACH, Fla. and TOKYO, April 20, 2026 (GLOBE NEWSWIRE) -- Anthony, Linder & Cacomanolis, PLLC (“ALC”), a premier international capital markets and U.S. securities law firm, provides a...
-
Adds Scaled, Integrated Productivity Solutions Platform with Strong Positions Across Key VerticalsExpands Total Addressable Market and Opens Enterprise Customer ChannelImmediately Double-Digit...
-
WILMINGTON, Del., April 20, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the...
-
Secures One of the Industry’s Most Strategic Operations as the Only Scaled Producer of all Four Magnetic Rare Earth Elements Outside Asia, along with a 15-Year 100% Offtake Agreement with a Special...
-
Dubai, UAE, April 19, 2026 (GLOBE NEWSWIRE) -- Pepeto dominates this week crypto news, where the team confirmed that presale demand hit its highest monthly pace yet with token entries growing every...
-
Marex Group plc Announces Pricing of U.S.$500 Million Senior Notes Offering
-
WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and...
-
SOUTH SAN FRANCISCO, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced the closing of its previously announced underwritten public offering of...
-
CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...